Infliximab-associated fulminant hepatic failure in ulcerative colitis: a case report

INTRODUCTION: Infliximab, an antibody against tumor necrosis factor alpha, is used to treat inflammatory bowel disease and has well-established efficacy and proven safety. Complications of this treatment are related to immunosuppression and include higher risk of serious infections and malignant neo...

Descripción completa

Detalles Bibliográficos
Autores principales: Parra, Rogerio Serafim, Feitosa, Marley Ribeiro, Machado, Vanessa Foresto, Ramalho, Leandra Naira Zambelli, Rocha, Jose Joaquim Ribeiro da, Feres, Omar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4627392/
https://www.ncbi.nlm.nih.gov/pubmed/26518665
http://dx.doi.org/10.1186/s13256-015-0730-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4627392/
https://www.ncbi.nlm.nih.gov/pubmed/26518665
http://dx.doi.org/10.1186/s13256-015-0730-5

Ejemplares similares